Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Stem Cell Reports|May 23, 2017
Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment OutcomesRafael Diaz de la Guardia, Belen Lopez-Millan, Jessie R Lavoie, et al.
Cancers|March 25, 2022
The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid LeukemiaBelen Lopez-Millan, Paula Costales, Francisco Gutiérrez-Agüera, et al.
Leukemia|September 15, 2025
CRISPR-engineered human GATA2 deficiency model uncovers mitotic dysfunction and premature aging in HSPCs, impairing hematopoietic fitnessDamia Romero-Moya, Eric Torralba-Sales, Cristina Calvo, et al.
Stem Cell Reports|August 13, 2019
GATA2 Promotes Hematopoietic Development and Represses Cardiac Differentiation of Human MesodermJulio Castaño, Sergi Aranda, Clara Bueno, et al.
Nature Communications|November 17, 2025
Human iPSCs-based modeling unveils SETBP1 as a driver of chromatin rewiring in GATA2 deficiencyJoan Pera, Damia Romero-Moya, Eric Torralba-Sales, et al.
Stem Cells (Dayton, Ohio)|May 5, 2017
Genetic Rescue of Mitochondrial and Skeletal Muscle Impairment in an Induced Pluripotent Stem Cells Model of Coenzyme Q<sub>10</sub> DeficiencyDamià Romero-Moya, Carlos Santos-Ocaña, Julio Castaño, et al.
Journal for Immunotherapy of Cancer|June 13, 2020
41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivoMatteo Libero Baroni, Diego Sanchez Martinez, Francisco Gutierrez Aguera, et al.
Molecular Therapy. Methods & Clinical Development|January 10, 2019
Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic InstitutionsMaria Castella, Anna Boronat, Raquel Martín-Ibáñez, et al.
Human Mutation|August 22, 2021
Altered regulation of BRCA1 exon 11 splicing is associated with breast cancer risk in carriers of BRCA1 pathogenic variantsGorka Ruiz de Garibay, Ignacio Fernandez-Garcia, Sylvie Mazoyer, et al.
Communications Biology|April 15, 2021
Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancerGiorgia Maroni, Mahmoud A Bassal, Indira Krishnan, et al.
Pageof 4